People | September 21, 2023
Parexel appoints Gwyn Bebb to lead oncology clinical development
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
Reinforces Henkel commitment to supporting customers and ecosystem in medical healthcare
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
The brand has launched 6 new range of products to provide a complete pregnancy care solution
Reblozyl is the first and only therapy to demonstrate superiority compared to an erythropoiesis stimulating agent (ESA) in MDS-related anemia
KEYTRUDA is the first immunotherapy approved in the EU for the first-line treatment of this patient population
Hospital joins with Intuitive to install da Vinci systems to support enhanced healthcare delivery and patient outcomes across India
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
Subscribe To Our Newsletter & Stay Updated
